WO2016024243A3 - Fidaxomicin polymorphs and processes for their preparation - Google Patents

Fidaxomicin polymorphs and processes for their preparation Download PDF

Info

Publication number
WO2016024243A3
WO2016024243A3 PCT/IB2015/056166 IB2015056166W WO2016024243A3 WO 2016024243 A3 WO2016024243 A3 WO 2016024243A3 IB 2015056166 W IB2015056166 W IB 2015056166W WO 2016024243 A3 WO2016024243 A3 WO 2016024243A3
Authority
WO
WIPO (PCT)
Prior art keywords
fidaxomicin
processes
preparation
polymorphs
relate
Prior art date
Application number
PCT/IB2015/056166
Other languages
French (fr)
Other versions
WO2016024243A2 (en
Inventor
Ramanaiah CHENNURU
Vishweshwar Peddy
Srividya Ramakrishnan
Original Assignee
Dr. Reddy’S Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy’S Laboratories Limited filed Critical Dr. Reddy’S Laboratories Limited
Publication of WO2016024243A2 publication Critical patent/WO2016024243A2/en
Publication of WO2016024243A3 publication Critical patent/WO2016024243A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Aspects of the present application relate to crystalline forms of Fidaxomicin IV, V & VI and processes for their preparation. Further aspects relate to pharmaceutical compositions comprising these polymorphic forms of fidaxomicin
PCT/IB2015/056166 2014-08-14 2015-08-13 Fidaxomicin polymorphs and processes for their preparation WO2016024243A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3999CH2014 2014-08-14
IN3999/CHE/2014 2014-08-14

Publications (2)

Publication Number Publication Date
WO2016024243A2 WO2016024243A2 (en) 2016-02-18
WO2016024243A3 true WO2016024243A3 (en) 2016-04-21

Family

ID=55304718

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/056166 WO2016024243A2 (en) 2014-08-14 2015-08-13 Fidaxomicin polymorphs and processes for their preparation

Country Status (1)

Country Link
WO (1) WO2016024243A2 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170142A1 (en) * 2012-05-10 2013-11-14 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013170142A1 (en) * 2012-05-10 2013-11-14 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof

Also Published As

Publication number Publication date
WO2016024243A2 (en) 2016-02-18

Similar Documents

Publication Publication Date Title
WO2016011222A3 (en) Circular polynucleotides
EP3402787A4 (en) Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof
WO2016079751A3 (en) A process for preparation of vortioxetine and polymorphs thereof
WO2015110897A3 (en) Novel process for the preparation of dolutegravir and pharmaceutically acceptable salts thereof
HK1232229A1 (en) Novel compound of 4-thionucleoside, as well as preparation method therefor, pharmaceutical composition thereof and application thereof 4-
WO2015104658A3 (en) Amorphous solid dispersion of dapagliflozin and process for the preparation of amorphous dapagliflozin
WO2015191945A3 (en) Solid state forms of sofosbuvir
WO2016071435A3 (en) Synthesis of copanlisib and its dihydrochloride salt
WO2016092561A3 (en) Novel polymorphs of ivacaftor, process for its preparation and pharmaceutical composition thereof
WO2016009401A3 (en) Preparation of tedizolid phosphate
WO2015121877A3 (en) Polymorphs of lomitapide and its salts
WO2016166720A3 (en) Polymorphs of afatinib and its salts and process for the preparation of quinazolinyl derivatives
EP3694499A4 (en) Novel process for the preparation of lifitegrast
WO2017008136A3 (en) Flourinated cbd compounds, compositions and uses thereof
WO2018069941A3 (en) Polymorphic forms of venetoclax
WO2016013030A3 (en) Hydroxysteroid compounds, their intermediates, process of preparation, composition and uses thereof
WO2015197534A3 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2016024286A3 (en) An improved process for synthesis of lenalidomide
WO2016063289A3 (en) Pharmaceutical tablet compositions comprising rifaximin
WO2015052568A3 (en) Solid forms of curcumin and derivatives thereof
WO2015181802A3 (en) Oral pharmaceutical composition of isotretinoin
WO2015001541A3 (en) Pharmaceutical film composition
EP3390369A4 (en) Solid forms of substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine compounds
WO2014195977A3 (en) Novel polymorphs of vismodegib
WO2016092442A8 (en) Processes for the preparation of crystalline forms of palbociclib acetate

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15831333

Country of ref document: EP

Kind code of ref document: A2